We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster.
- Authors
Dews, Michael; Homayouni, Asal; Yu, Duonan; Murphy, Danielle; Sevignani, Cinzia; Wentzel, Erik; Furth, Emma E.; Lee, William M.; Enders, Greg H.; Mendell, Joshua T.; Thomas-Tikhonenko, Andrei
- Abstract
Human adenocarcinomas commonly harbor mutations in the KRAS and MYC proto-oncogenes and the TP53 tumor suppressor gene. All three genetic lesions are potentially pro-angiogenic, as they sustain production of vascular endothelial growth factor (VEGF). Yet Kras-transformed mouse colonocytes lacking p53 formed indolent, poorly vascularized tumors, whereas additional transduction with a Myc-encoding retrovirus promoted vigorous vascularization and growth. In addition, VEGF levels were unaffected by Myc, but enhanced neovascularization correlated with downregulation of anti-angiogenic thrombospondin-1 (Tsp1) and related proteins, such as connective tissue growth factor (CTGF). Both Tsp1 and CTGF are predicted targets for repression by the miR-17-92 microRNA cluster, which was upregulated in colonocytes coexpressing K-Ras and c-Myc. Indeed, miR-17-92 knockdown with antisense 2′-O-methyl oligoribonucleotides partly restored Tsp1 and CTGF expression; in addition, transduction of Ras-only cells with a miR-17-92–encoding retrovirus reduced Tsp1 and CTGF levels. Notably, miR-17-92–transduced cells formed larger, better-perfused tumors. These findings establish a role for microRNAs in non–cell-autonomous Myc-induced tumor phenotypes.
- Subjects
ADENOCARCINOMA; NEOVASCULARIZATION inhibitors; GENETIC mutation; TUMOR suppressor genes; VASCULAR endothelial growth factors; GENETIC research
- Publication
Nature Genetics, 2006, Vol 38, Issue 9, p1060
- ISSN
1061-4036
- Publication type
Article
- DOI
10.1038/ng1855